Schonfeld Strategic Advisors LLC Iovance Biotherapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$13.8 Billion
Q3 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 395,447 shares of IOVA stock, worth $3.38 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

395,447

Holding current value

$3.38 Million

% of portfolio

0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.28 - $11.9 $2.88 Million - $4.71 Million	395,447 New	395,447 $3.71 Million
Q1 2024 May 15, 2024	SELL	$7.59 - $17.47 $5.9 Million - $13.6 Million	-777,371 Reduced 76.08%	244,447 $3.62 Million
Q4 2023 Feb 14, 2024	BUY	$3.3 - $8.89 $3.37 Million - $9.08 Million	1,021,818 New	1,021,818 $8.31 Million
Q2 2023 Aug 14, 2023	SELL	$5.36 - $9.06 $1.42 Million - $2.41 Million	-265,767 Reduced 87.85%	36,751 $258,000
Q1 2023 May 15, 2023	SELL	$5.53 - $8.22 $3.85 Million - $5.72 Million	-695,582 Reduced 69.69%	302,518 $1.85 Million
Q4 2022 Feb 14, 2023	BUY	$5.62 - $10.0 $4.64 Million - $8.25 Million	824,917 Added 476.33%	998,100 $6.38 Million
Q3 2022 Nov 14, 2022	BUY	$9.53 - $13.11 $1.65 Million - $2.27 Million	173,183 New	173,183 $1.66 Million
Q4 2021 Feb 14, 2022	SELL	$16.55 - $27.63 $1.52 Million - $2.53 Million	-91,641 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$20.35 - $26.63 $1.68 Million - $2.2 Million	82,441 Added 896.1%	91,641 $2.26 Million
Q2 2021 Nov 16, 2021	SELL	$16.33 - $33.07 $1.27 Million - $2.56 Million	-77,500 Reduced 89.39%	9,200 $239,000
Q2 2021 Aug 16, 2021	BUY	$16.33 - $33.07 $934,059 - $1.89 Million	57,199 Added 193.89%	86,700 $2.26 Million
Q1 2021 May 17, 2021	BUY	$28.67 - $52.59 $606,915 - $1.11 Million	21,169 Added 254.07%	29,501 $935,000
Q4 2020 Feb 16, 2021	SELL	$28.04 - $50.26 $1.2 Million - $2.14 Million	-42,637 Reduced 83.65%	8,332 $387,000
Q3 2020 Nov 16, 2020	BUY	$27.75 - $36.3 $211,177 - $276,243	7,610 Added 17.55%	50,969 $2,000
Q2 2020 Aug 14, 2020	BUY	$27.21 - $41.0 $849,605 - $1.28 Million	31,224 Added 257.31%	43,359 $1.19 Million
Q1 2020 May 15, 2020	SELL	$19.54 - $38.85 $4.2 Million - $8.34 Million	-214,716 Reduced 94.65%	12,135 $363,000
Q4 2019 Feb 14, 2020	BUY	$17.95 - $29.41 $1.51 Million - $2.48 Million	84,251 Added 59.08%	226,851 $6.28 Million
Q3 2019 Nov 14, 2019	BUY	$17.99 - $26.0 $2.21 Million - $3.19 Million	122,800 Added 620.2%	142,600 $2.6 Million
Q2 2019 Aug 14, 2019	SELL	$9.78 - $24.52 $1.65 Million - $4.13 Million	-168,630 Reduced 89.49%	19,800 $485,000
Q1 2019 May 15, 2019	SELL	$8.41 - $11.26 $6.31 Million - $8.44 Million	-749,870 Reduced 79.92%	188,430 $1.79 Million
Q4 2018 Feb 14, 2019	BUY	$7.51 - $11.93 $7.05 Million - $11.2 Million	938,300 New	938,300 $8.3 Million
Q2 2018 Aug 14, 2018	SELL	$12.45 - $16.95 $367,785 - $500,719	-29,541 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$8.1 - $19.5 $239,282 - $576,049	29,541 New	29,541 $499,000

Others Institutions Holding IOVA

# of Institutions

314

Shares Held

241M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.35B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Iovance Biotherapeutics, Inc. Transaction History